Poster 6: Traumatic brain injury as a relevant cause of growth hormone deficiency in adults. Experience from KIMS (pharmacia international metabolic database)

Objective: To compare baseline clinical characteristics and 1-year growth hormone (GH) replacement results in patients with adult onset growth hormone deficiency (GHD) caused by traumatic brain injury (TBI) versus nonfunctioning pituitary adenoma (NFPA). Design: Pharmacoepidemiologic survey of hypopituitary adults with GHD. Setting: Records were selected from the KIMS database, which contains information on >8500 patients with GHD, for 168 of whom TBI was identified as a cause. Participants: Both groups (NFPA group, n=207; TBI group, n=29) were age- (at pituitary disorder onset and entry into the KIMS database) and sex-matched (60% men, 40% women), previously not irradiated, and had not received GH. Interventions: Not applicable. Main Outcome Measures: Values given as mean ± SE. Results: The age at GHD diagnosis was 38.8±2.0 years for the TBI group and 41.5±0.5 years for the NFPA group. In both groups, the most frequent additional hypopituitary deficiency was luteinzing hormone/follicle-stimulating hormone, followed by adrenocorticotropic hormone and thyroid-stimulating hormone. The mean GH peak at diagnosis was 1.25±0.42ng/mL in the TBI group, which was significantly lower than that of the NFPA group (2.38±0.7ng/mL). There were no significant statistical differences in medical history, glucose level, lipids, waist circumference, or body composition measurements. Interestingly, patients with TBI were significantly shorter (168.2±1.5cm) than the NFPA patients (172.5±0.6cm). After 1 year of GH treatment, differences were shown in waist, lean mass, heart rate, glucose levels, quality of life as measured by the Quality of Life Assessment in Growth Hormone Deficient Adults and insulin-like growth factor I. Conclusions: Although hypopituitarism secondary to TBI was described more than 50 years ago, it is only now evident that a considerable number of patients experience severe GHD after TBI. It is suspected that a large number of patients after TBI have undiagnosed GHD. The present results confirm that clinical characteristics and GH treatment effects in GHD caused by TBI are indistinguishable from those in GHD caused by NFPA.     

Levonorgestrel. The day-after pill

Only making use of Levonorgestrel as a post intercourse anti-conceptive method has proven to be more effective than prior methods and is the object under study in this report. This post intercourse anti-conceptive consists of a set of methods which, employed after at risk sexual intercourse and within a maximum period of time, avoid pregnancy. This post intercourse anti-conceptive is not considered to be an abortion method but it should not be used as a habitual anti-conceptive method due to its adverse effects and its numerous interactions with other pharmaceutical products. Its use shall be limited to emergency situations. Special emphasis must be given as part of health education to females who employ this technique. As health professionals, we need to know this topic in depth so that we can best advise those persons in need of information. The authors propose to provide general information about aspects related to this pharmaceutical product.     

Thyroid function alterations in children with congenital cardiac disease after catheterization with iodinated contrast agents

INTRODUCTION AND OBJECTIVES: Iodinated contrast agents can block thyroid hormone synthesis. The aims of this study were: 1st) to study the incidence of thyroid function disturbances in children with congenital heart disease after cardiac catheterization, 2nd) to analyze the predisposing factors that may lead to the development of hypothyroidism after angiography, and 3rd) to determine the duration of these hypothyroidism states. PATIENTS AND METHODS: From february 1993 to April 1997 thyrotropine (TSH) and free thyroxine (FT4) serum values were analyzed before cardiac catheterization and in the two following weeks, in 99 children under three years of age, with congenital cardiac disease. Those patients who showed any postangiography increase in TSH were further evaluated by weekly measures of serum thyroid hormones and TSH until normal values were obtained or until the initiation of hormonal replacement therapy. The patients' data (age, previous exposure to contrast agents, cardiac disease, associated extracardiac malformations, renal failure, severity of illness, treatment) and the catheterism data (the dose and type of contrast and the fluoroscopy time) were included in the univariant analysis. RESULTS: 10 mUI/ml), that persisted beyond three weeks in six cases. The occurrence of multiple malformation syndromes was the most clearly associated risk factor (p < 0,01) not only in the development of postangiography hypothyroidism but also in longer hormonal dysfunction. CONCLUSIONS: Thyroid function should be tested in every patient with multiple malformation syndrome that undergo angiocardiography with iodinated contrast agents.     

Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels

Changes in body composition, hormone secretions, and heart function with increased risk of sudden death occur in eating disorders. In this observational clinical study, we evaluated sympathovagal modulation of heart rate variability (HRV) and cardiovascular changes in response to lying-to-standing in patients with anorexia (AN) or bulimia nervosa (BN) to analyze: a) differences in autonomic activity between AN, BN, and healthy subjects; b) relationships between autonomic and cardiovascular parameters, clinical data and leptin levels in patients with eating disorders. HRV, assessed by power spectral analysis of R-R intervals, blood pressure (BP) and heart rate (HR) were studied by tilt-table test in 34 patients with AN, 16 with BN and 30 healthy controls. Autonomic and cardiovascular findings were correlated with clinical data, and serum leptin levels. Leptin levels were lowered in AN vs BN and healthy subjects (p<0.0001), but both AN and BN patients showed unbalanced sympathovagal control of HRV due to relative sympathetic failure, prevalent vagal activity, impaired sympathetic activation after tilting, independently from their actual body weight and leptin levels. No significant correlations were obtained between HRV data vs clinical data, BP and HR findings, and leptin levels in eating disorders. Body mass indices (BMI) (p<0.02), and leptin levels (p<0.04) correlated directly with BP values. Our data showed alterations of sympathovagal control of HRV in eating disorders. These changes were unrelated to body weight and BMI, diagnosis of AN or BN, and leptin levels despite the reported effects of leptin on the sympathetic activity.     

Testing the use of a citronella-based repellent as an effective method to reduce the prevalence and abundance of biting flies in avian nests

Here, we validate the use of a citronella (natural oil) based repellent to reduce the abundance of flying blood-sucking insects in avian nests. These insects are important parasites of birds affecting them as blood feeders and as vectors of a diversity of pathogens. When nestling were 10 days old, we assigned wild great tit Parus major nests to one of two treatments, control and fumigated nests. The abundance of biting midges and blackflies captured during 3 days following the treatment application were lower in fumigated nests with respect to control ones. By contrast, the abundance of blowfly pupae measured when nestlings left their nests was not affected by the treatment. Although many experimental studies modify the abundance of nest-dweller ectoparasites, to our knowledge, this is the first one describing an easy, safe, and effective method, reducing the total abundance of both biting midges and blackflies in wild avian nests. Our results could be used in future conservation projects and experimental studies on host–parasite evolution affecting the abundance of flying blood-feeder insects under natural conditions.     

Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions

Oligometastatic non-small cell lung cancer (NSCLC) describes an intermediate stage of NSCLC between localized and widely-disseminated disease. This stage of NSCLC is characterized by a limited number of metastases and a more indolent tumor biology. Currently, the management of oligometastatic NSCLC involves radical treatment (radiotherapy or surgery) that targets the metastatic lesions and the primary tumor to achieve disease control. This approach offers the potential to achieve prolonged survival in patients who, in the past, would have only received palliative measures. The optimal therapeutic strategies for the different scenarios of oligometastatic disease (intracranial vs extracranial disease, synchronous vs metachronous) remain undefined. Given the lack of head-to-head studies comparing radiotherapy to surgery in these patients, the decision to apply surgery or radiotherapy (with or without systemic treatment) must be based on prognostic factors that allow us to classify patients. This classification will allow us to select the most appropriate therapeutic strategy on an individualized basis. In the future, the molecular or microRNA profiles will likely improve the treatment selection process. The objective of the present article is to review the most relevant scientific evidence on the management of patients with oligometastatic NSCLC, focusing on the role of radiotherapy and surgery. We also discuss areas of controversy and future directions.